[{"edinetCode":"E03446","endDate":"2017\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3533.0,"averageTemporaryStaff":10910.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":14194000.0,"sharesOwendPercent":0.7097,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":4699.76,"equityRatio":0.412,"cashAndCashEquivalents":27728000000.0,"assets":225691000000.0,"currentAssets":73749000000.0,"fixedAsset":151942000000.0,"tangibleFixedAssets":134450000000.0,"intangibleFixedAssets":215000000.0,"investmentAndOtherAssets":17276000000.0,"liabilities":132638000000.0,"currentLiabilities":114132000000.0,"shorTermDept":4486000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":18506000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":11747000000.0,"netAsset":93053000000.0,"capitalStock":93125000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":84575000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-72000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":502732000000.0,"costOfSales":402688000000.0,"grossProfit":100044000000.0,"sgaExpenses":77806000000.0,"salaryAndBenefit":null,"depreciationAndSGA":9709000000.0,"RDExpenses":null,"operatingIncome":22237000000.0,"nonOperatingIncome":3243000000.0,"nonOperatingExpenses":889000000.0,"interestExpense":98000000.0,"ordinaryProfit":24591000000.0,"extraordinaryGain":1676000000.0,"extraordinaryLoss":530000000.0,"incomeBeforeTax":25737000000.0,"incomeTaxes":7522000000.0,"netIncome":18215000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":18215000000.0,"comprehensiveIncome":18260000000.0,"eps":919.99,"dilutedEps":null,"dividendPerShare":null,"per":25.4,"roe":0.215,"cashFlowFromOperatingActivities":36938000000.0,"depreciationAndCashflowFromOperatingActivities":10710000000.0,"cashFlowFromInvestingActivities":-28404000000.0,"cashFlowFromFinancialActivities":-8088000000.0,"changesInCashAndCashEquivalents":445000000.0,"列1":"asr","submitDate":"2017\/8\/30","stockCode":3349,"accountingYear":"第35期(自　平成28年６月１日　至　平成29年５月31日)","accountingYearStart":"2016\/6\/1","accountingYearEnd":"2017\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2018\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3849.0,"averageTemporaryStaff":12199.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":14129000.0,"sharesOwendPercent":0.7137,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":5499.55,"equityRatio":0.434,"cashAndCashEquivalents":21668000000.0,"assets":250609000000.0,"currentAssets":78073000000.0,"fixedAsset":172535000000.0,"tangibleFixedAssets":153976000000.0,"intangibleFixedAssets":295000000.0,"investmentAndOtherAssets":18262000000.0,"liabilities":141720000000.0,"currentLiabilities":126436000000.0,"shorTermDept":3199000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":15283000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8548000000.0,"netAsset":108888000000.0,"capitalStock":108977000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":100426000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-88000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":557999000000.0,"costOfSales":447681000000.0,"grossProfit":110317000000.0,"sgaExpenses":87568000000.0,"salaryAndBenefit":null,"depreciationAndSGA":10888000000.0,"RDExpenses":null,"operatingIncome":22749000000.0,"nonOperatingIncome":3257000000.0,"nonOperatingExpenses":751000000.0,"interestExpense":88000000.0,"ordinaryProfit":25255000000.0,"extraordinaryGain":89000000.0,"extraordinaryLoss":176000000.0,"incomeBeforeTax":25167000000.0,"incomeTaxes":7534000000.0,"netIncome":17633000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":17633000000.0,"comprehensiveIncome":17617000000.0,"eps":890.59,"dilutedEps":null,"dividendPerShare":null,"per":26.3,"roe":0.175,"cashFlowFromOperatingActivities":32586000000.0,"depreciationAndCashflowFromOperatingActivities":11885000000.0,"cashFlowFromInvestingActivities":-30458000000.0,"cashFlowFromFinancialActivities":-8188000000.0,"changesInCashAndCashEquivalents":-6060000000.0,"列1":"asr","submitDate":"2018\/8\/30","stockCode":3349,"accountingYear":"第36期(自　平成29年６月１日　至　平成30年５月31日)","accountingYearStart":"2017\/6\/1","accountingYearEnd":"2018\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2019\/2\/28","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.462,"cashAndCashEquivalents":null,"assets":260470000000.0,"currentAssets":75597000000.0,"fixedAsset":184873000000.0,"tangibleFixedAssets":165194000000.0,"intangibleFixedAssets":241000000.0,"investmentAndOtherAssets":19437000000.0,"liabilities":140139000000.0,"currentLiabilities":125884000000.0,"shorTermDept":6500000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1574000000.0,"fixedLiabilities":14254000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7433000000.0,"netAsset":120331000000.0,"capitalStock":120403000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":111852000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-71000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":450487000000.0,"costOfSales":360661000000.0,"grossProfit":89826000000.0,"sgaExpenses":71800000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":18025000000.0,"nonOperatingIncome":2207000000.0,"nonOperatingExpenses":546000000.0,"interestExpense":58000000.0,"ordinaryProfit":19686000000.0,"extraordinaryGain":329000000.0,"extraordinaryLoss":528000000.0,"incomeBeforeTax":19487000000.0,"incomeTaxes":6279000000.0,"netIncome":13207000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":13207000000.0,"comprehensiveIncome":13224000000.0,"eps":667.09,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/4\/12","stockCode":3349,"accountingYear":null,"accountingYearStart":"2018\/6\/1","accountingYearEnd":"2019\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2019\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":4240.0,"averageTemporaryStaff":13441.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":13882000.0,"sharesOwendPercent":0.7012,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":6378.39,"equityRatio":0.462,"cashAndCashEquivalents":19022000000.0,"assets":273561000000.0,"currentAssets":80385000000.0,"fixedAsset":193176000000.0,"tangibleFixedAssets":172816000000.0,"intangibleFixedAssets":287000000.0,"investmentAndOtherAssets":20071000000.0,"liabilities":147272000000.0,"currentLiabilities":133170000000.0,"shorTermDept":1486000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":14101000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7061000000.0,"netAsset":126289000000.0,"capitalStock":126380000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":117829000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-91000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":611137000000.0,"costOfSales":489353000000.0,"grossProfit":121784000000.0,"sgaExpenses":97008000000.0,"salaryAndBenefit":null,"depreciationAndSGA":11958000000.0,"RDExpenses":null,"operatingIncome":24775000000.0,"nonOperatingIncome":3237000000.0,"nonOperatingExpenses":719000000.0,"interestExpense":77000000.0,"ordinaryProfit":27292000000.0,"extraordinaryGain":362000000.0,"extraordinaryLoss":516000000.0,"incomeBeforeTax":27139000000.0,"incomeTaxes":7954000000.0,"netIncome":19185000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":19185000000.0,"comprehensiveIncome":19182000000.0,"eps":968.97,"dilutedEps":null,"dividendPerShare":null,"per":17.7,"roe":0.163,"cashFlowFromOperatingActivities":34379000000.0,"depreciationAndCashflowFromOperatingActivities":12958000000.0,"cashFlowFromInvestingActivities":-30042000000.0,"cashFlowFromFinancialActivities":-6982000000.0,"changesInCashAndCashEquivalents":-2646000000.0,"列1":"asr","submitDate":"2019\/8\/29","stockCode":3349,"accountingYear":"第37期(自　2018年６月１日　至　2019年５月31日)","accountingYearStart":"2018\/6\/1","accountingYearEnd":"2019\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2019\/8\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.476,"cashAndCashEquivalents":null,"assets":273737000000.0,"currentAssets":78084000000.0,"fixedAsset":195652000000.0,"tangibleFixedAssets":175294000000.0,"intangibleFixedAssets":272000000.0,"investmentAndOtherAssets":20084000000.0,"liabilities":143481000000.0,"currentLiabilities":129727000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1486000000.0,"fixedLiabilities":13753000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6689000000.0,"netAsset":130256000000.0,"capitalStock":130341000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":121790000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-84000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":164500000000.0,"costOfSales":131454000000.0,"grossProfit":33045000000.0,"sgaExpenses":26022000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":7023000000.0,"nonOperatingIncome":710000000.0,"nonOperatingExpenses":201000000.0,"interestExpense":18000000.0,"ordinaryProfit":7532000000.0,"extraordinaryGain":null,"extraordinaryLoss":103000000.0,"incomeBeforeTax":7428000000.0,"incomeTaxes":2379000000.0,"netIncome":5049000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5049000000.0,"comprehensiveIncome":5056000000.0,"eps":255.05,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/10\/15","stockCode":3349,"accountingYear":null,"accountingYearStart":"2019\/6\/1","accountingYearEnd":"2020\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2019\/11\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":13579000.0,"sharesOwendPercent":0.6858,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.481,"cashAndCashEquivalents":17182000000.0,"assets":278727000000.0,"currentAssets":79883000000.0,"fixedAsset":198843000000.0,"tangibleFixedAssets":178418000000.0,"intangibleFixedAssets":258000000.0,"investmentAndOtherAssets":20166000000.0,"liabilities":144743000000.0,"currentLiabilities":131300000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1486000000.0,"fixedLiabilities":13443000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6318000000.0,"netAsset":133983000000.0,"capitalStock":134062000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":125511000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-78000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":325269000000.0,"costOfSales":260684000000.0,"grossProfit":64584000000.0,"sgaExpenses":52619000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":11965000000.0,"nonOperatingIncome":1552000000.0,"nonOperatingExpenses":408000000.0,"interestExpense":35000000.0,"ordinaryProfit":13110000000.0,"extraordinaryGain":2000000.0,"extraordinaryLoss":167000000.0,"incomeBeforeTax":12945000000.0,"incomeTaxes":4174000000.0,"netIncome":8771000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":8771000000.0,"comprehensiveIncome":8783000000.0,"eps":443.0,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":13874000000.0,"depreciationAndCashflowFromOperatingActivities":6602000000.0,"cashFlowFromInvestingActivities":-12936000000.0,"cashFlowFromFinancialActivities":-2777000000.0,"changesInCashAndCashEquivalents":-1840000000.0,"列1":"q2r","submitDate":"2020\/1\/14","stockCode":3349,"accountingYear":null,"accountingYearStart":"2019\/6\/1","accountingYearEnd":"2020\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2020\/2\/29","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.491,"cashAndCashEquivalents":null,"assets":281831000000.0,"currentAssets":80186000000.0,"fixedAsset":201644000000.0,"tangibleFixedAssets":181092000000.0,"intangibleFixedAssets":251000000.0,"investmentAndOtherAssets":20300000000.0,"liabilities":143364000000.0,"currentLiabilities":130456000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1486000000.0,"fixedLiabilities":12907000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5946000000.0,"netAsset":138467000000.0,"capitalStock":138540000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":129990000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-73000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":492877000000.0,"costOfSales":394651000000.0,"grossProfit":98226000000.0,"sgaExpenses":78791000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":19434000000.0,"nonOperatingIncome":2337000000.0,"nonOperatingExpenses":570000000.0,"interestExpense":52000000.0,"ordinaryProfit":21201000000.0,"extraordinaryGain":19000000.0,"extraordinaryLoss":224000000.0,"incomeBeforeTax":20996000000.0,"incomeTaxes":6757000000.0,"netIncome":14239000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":14239000000.0,"comprehensiveIncome":14257000000.0,"eps":719.17,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/4\/14","stockCode":3349,"accountingYear":null,"accountingYearStart":"2019\/6\/1","accountingYearEnd":"2020\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2020\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":4386.0,"averageTemporaryStaff":14678.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12965000.0,"sharesOwendPercent":0.6548,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":3678.76,"equityRatio":0.455,"cashAndCashEquivalents":52122000000.0,"assets":320283000000.0,"currentAssets":114150000000.0,"fixedAsset":206132000000.0,"tangibleFixedAssets":185374000000.0,"intangibleFixedAssets":268000000.0,"investmentAndOtherAssets":20489000000.0,"liabilities":174607000000.0,"currentLiabilities":161950000000.0,"shorTermDept":1486000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":12657000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5574000000.0,"netAsset":145675000000.0,"capitalStock":145736000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":137185000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-60000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":684403000000.0,"costOfSales":549419000000.0,"grossProfit":134984000000.0,"sgaExpenses":105890000000.0,"salaryAndBenefit":null,"depreciationAndSGA":12543000000.0,"RDExpenses":null,"operatingIncome":29094000000.0,"nonOperatingIncome":3219000000.0,"nonOperatingExpenses":751000000.0,"interestExpense":69000000.0,"ordinaryProfit":31562000000.0,"extraordinaryGain":5000000.0,"extraordinaryLoss":1166000000.0,"incomeBeforeTax":30402000000.0,"incomeTaxes":8967000000.0,"netIncome":21435000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":21435000000.0,"comprehensiveIncome":21465000000.0,"eps":541.3,"dilutedEps":null,"dividendPerShare":null,"per":28.6,"roe":0.158,"cashFlowFromOperatingActivities":65461000000.0,"depreciationAndCashflowFromOperatingActivities":13562000000.0,"cashFlowFromInvestingActivities":-26956000000.0,"cashFlowFromFinancialActivities":-5405000000.0,"changesInCashAndCashEquivalents":33100000000.0,"列1":"asr","submitDate":"2020\/8\/28","stockCode":3349,"accountingYear":"第38期(自　2019年６月１日　至　2020年５月31日)","accountingYearStart":"2019\/6\/1","accountingYearEnd":"2020\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2020\/8\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.482,"cashAndCashEquivalents":null,"assets":315351000000.0,"currentAssets":109223000000.0,"fixedAsset":206128000000.0,"tangibleFixedAssets":185580000000.0,"intangibleFixedAssets":255000000.0,"investmentAndOtherAssets":20292000000.0,"liabilities":163369000000.0,"currentLiabilities":151101000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1486000000.0,"fixedLiabilities":12268000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":5203000000.0,"netAsset":151982000000.0,"capitalStock":152038000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":143488000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-55000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":189161000000.0,"costOfSales":150923000000.0,"grossProfit":38238000000.0,"sgaExpenses":27582000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":10655000000.0,"nonOperatingIncome":771000000.0,"nonOperatingExpenses":207000000.0,"interestExpense":15000000.0,"ordinaryProfit":11220000000.0,"extraordinaryGain":null,"extraordinaryLoss":237000000.0,"incomeBeforeTax":10983000000.0,"incomeTaxes":3492000000.0,"netIncome":7490000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":7490000000.0,"comprehensiveIncome":7494000000.0,"eps":189.15,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/10\/14","stockCode":3349,"accountingYear":null,"accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2020\/11\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":25634000.0,"sharesOwendPercent":0.6473,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.5,"cashAndCashEquivalents":39678000000.0,"assets":315325000000.0,"currentAssets":106357000000.0,"fixedAsset":208967000000.0,"tangibleFixedAssets":188278000000.0,"intangibleFixedAssets":293000000.0,"investmentAndOtherAssets":20395000000.0,"liabilities":157756000000.0,"currentLiabilities":145814000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1486000000.0,"fixedLiabilities":11941000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4831000000.0,"netAsset":157569000000.0,"capitalStock":157620000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":149070000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-51000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":364175000000.0,"costOfSales":290551000000.0,"grossProfit":73623000000.0,"sgaExpenses":55330000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":18292000000.0,"nonOperatingIncome":1639000000.0,"nonOperatingExpenses":383000000.0,"interestExpense":31000000.0,"ordinaryProfit":19547000000.0,"extraordinaryGain":10000000.0,"extraordinaryLoss":336000000.0,"incomeBeforeTax":19221000000.0,"incomeTaxes":6149000000.0,"netIncome":13072000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":13072000000.0,"comprehensiveIncome":13081000000.0,"eps":330.12,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-652000000.0,"depreciationAndCashflowFromOperatingActivities":6714000000.0,"cashFlowFromInvestingActivities":-8979000000.0,"cashFlowFromFinancialActivities":-2811000000.0,"changesInCashAndCashEquivalents":-12443000000.0,"列1":"q2r","submitDate":"2021\/1\/14","stockCode":3349,"accountingYear":null,"accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2021\/2\/28","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.517,"cashAndCashEquivalents":null,"assets":319240000000.0,"currentAssets":111740000000.0,"fixedAsset":207500000000.0,"tangibleFixedAssets":186778000000.0,"intangibleFixedAssets":292000000.0,"investmentAndOtherAssets":20429000000.0,"liabilities":154246000000.0,"currentLiabilities":142814000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1486000000.0,"fixedLiabilities":11431000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4459000000.0,"netAsset":164993000000.0,"capitalStock":165040000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":156490000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-46000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":541697000000.0,"costOfSales":432868000000.0,"grossProfit":108828000000.0,"sgaExpenses":82817000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":26010000000.0,"nonOperatingIncome":2426000000.0,"nonOperatingExpenses":578000000.0,"interestExpense":46000000.0,"ordinaryProfit":27859000000.0,"extraordinaryGain":4234000000.0,"extraordinaryLoss":387000000.0,"incomeBeforeTax":31705000000.0,"incomeTaxes":10124000000.0,"netIncome":21581000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":21581000000.0,"comprehensiveIncome":21595000000.0,"eps":545.0,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/4\/14","stockCode":3349,"accountingYear":null,"accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2021\/5\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":4872.0,"averageTemporaryStaff":16167.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":25714000.0,"sharesOwendPercent":0.6494,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":4307.63,"equityRatio":0.5,"cashAndCashEquivalents":55108000000.0,"assets":341318000000.0,"currentAssets":125125000000.0,"fixedAsset":216192000000.0,"tangibleFixedAssets":195131000000.0,"intangibleFixedAssets":326000000.0,"investmentAndOtherAssets":20735000000.0,"liabilities":170740000000.0,"currentLiabilities":159537000000.0,"shorTermDept":1486000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":11203000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4088000000.0,"netAsset":170578000000.0,"capitalStock":170615000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":162065000000.0,"treasuryStock":-238000000.0,"valuationAndConversionAdjustments":-37000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":726424000000.0,"costOfSales":581313000000.0,"grossProfit":145111000000.0,"sgaExpenses":111964000000.0,"salaryAndBenefit":null,"depreciationAndSGA":12801000000.0,"RDExpenses":null,"operatingIncome":33147000000.0,"nonOperatingIncome":3424000000.0,"nonOperatingExpenses":736000000.0,"interestExpense":60000000.0,"ordinaryProfit":35835000000.0,"extraordinaryGain":4267000000.0,"extraordinaryLoss":1506000000.0,"incomeBeforeTax":38596000000.0,"incomeTaxes":11439000000.0,"netIncome":27156000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":27156000000.0,"comprehensiveIncome":27179000000.0,"eps":685.8,"dilutedEps":null,"dividendPerShare":null,"per":22.2,"roe":0.172,"cashFlowFromOperatingActivities":27875000000.0,"depreciationAndCashflowFromOperatingActivities":13785000000.0,"cashFlowFromInvestingActivities":-19381000000.0,"cashFlowFromFinancialActivities":-5507000000.0,"changesInCashAndCashEquivalents":2985000000.0,"列1":"asr","submitDate":"2021\/8\/30","stockCode":3349,"accountingYear":"第39期(自　2020年６月１日　至　2021年５月31日)","accountingYearStart":"2020\/6\/1","accountingYearEnd":"2021\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2021\/8\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.51,"cashAndCashEquivalents":null,"assets":343640000000.0,"currentAssets":121842000000.0,"fixedAsset":221798000000.0,"tangibleFixedAssets":200581000000.0,"intangibleFixedAssets":328000000.0,"investmentAndOtherAssets":20888000000.0,"liabilities":168498000000.0,"currentLiabilities":157781000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1486000000.0,"fixedLiabilities":10716000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3716000000.0,"netAsset":175142000000.0,"capitalStock":175176000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":166626000000.0,"treasuryStock":-239000000.0,"valuationAndConversionAdjustments":-33000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":189409000000.0,"costOfSales":151420000000.0,"grossProfit":37988000000.0,"sgaExpenses":29432000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":8556000000.0,"nonOperatingIncome":892000000.0,"nonOperatingExpenses":147000000.0,"interestExpense":13000000.0,"ordinaryProfit":9301000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":88000000.0,"incomeBeforeTax":9213000000.0,"incomeTaxes":2969000000.0,"netIncome":6243000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":6243000000.0,"comprehensiveIncome":6247000000.0,"eps":157.68,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/10\/14","stockCode":3349,"accountingYear":null,"accountingYearStart":"2021\/6\/1","accountingYearEnd":"2022\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0},{"edinetCode":"E03446","endDate":"2021\/11\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":27432000.0,"sharesOwendPercent":0.6928,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.52,"cashAndCashEquivalents":41508000000.0,"assets":346135000000.0,"currentAssets":117607000000.0,"fixedAsset":228528000000.0,"tangibleFixedAssets":207023000000.0,"intangibleFixedAssets":397000000.0,"investmentAndOtherAssets":21107000000.0,"liabilities":165988000000.0,"currentLiabilities":155380000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":1431000000.0,"fixedLiabilities":10608000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3400000000.0,"netAsset":180147000000.0,"capitalStock":180177000000.0,"capital":4178000000.0,"capitalSurplus":4610000000.0,"accumulatedEarnings":171628000000.0,"treasuryStock":-240000000.0,"valuationAndConversionAdjustments":-30000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":371138000000.0,"costOfSales":296944000000.0,"grossProfit":74193000000.0,"sgaExpenses":59214000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":14979000000.0,"nonOperatingIncome":1847000000.0,"nonOperatingExpenses":332000000.0,"interestExpense":27000000.0,"ordinaryProfit":16494000000.0,"extraordinaryGain":268000000.0,"extraordinaryLoss":127000000.0,"incomeBeforeTax":16636000000.0,"incomeTaxes":5390000000.0,"netIncome":11245000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":11245000000.0,"comprehensiveIncome":11253000000.0,"eps":283.99,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":7069000000.0,"depreciationAndCashflowFromOperatingActivities":7091000000.0,"cashFlowFromInvestingActivities":-17371000000.0,"cashFlowFromFinancialActivities":-3297000000.0,"changesInCashAndCashEquivalents":-13599000000.0,"列1":"q2r","submitDate":"2022\/1\/14","stockCode":3349,"accountingYear":null,"accountingYearStart":"2021\/6\/1","accountingYearEnd":"2022\/5\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03446","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":4178,"settlementDate":"2022\/5\/31","submitterName":"株式会社コスモス薬品","submitterNameEnglish":"COSMOS Pharmaceutical Corporation","submitterNameKana":"カブシキガイシャコスモスヤクヒン","location":"福岡市博多区博多駅東二丁目１０番１号　第一福岡ビルＳ館４階","industory":"小売業","corporateNumber":9290000000000.0}]